Stock listing

Frankfurt:0N6A TME Pharma N.V. Aktie

German listing (Frankfurt) of TME Pharma N.V. · home listing Euronext:ALTME

Follow TME Pharma N.V. into a list and get an email when it puts out news.

Share price · FWB:0N6A

€0.103 EUR -0.001 (-1.0%)

Close on Nov 17, 2026

Past year +58.8% · daily closes, Nov 17, 2025 – Nov 6, 2026, adjusted for splits
Day range
€0.102 – €0.103 EURNov 17, 2026
Market cap
€9.78M EURAt the close on Nov 17, 2026 · price × 94.99M shares outstanding
52-week range
€0.033 – €0.178 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
Traded on an average day
€18,266 EURMedian day 0 shares · 38 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026
TME Pharma N.V. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ALTME · Home€0.106 EUR-0.001 (-0.9%)835,044€0.107€0.107€0.104€0.107Close on Nov 17, 2026
Frankfurt:0N6A€0.103 EUR-0.001 (-1.0%)—€0.103€0.103€0.102€0.104Close on Nov 17, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:0N6A · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.108-0.003-2.7%€0.098€0.108€0.0970
€0.111+0.007+6.7%€0.096€0.112€0.095508,242
€0.1040.0000.0%€0.100€0.106€0.100508,242
€0.104-0.006-5.5%€0.101€0.106€0.1018,696
€0.110-0.018-14.1%€0.111€0.116€0.1107,634
€0.128+0.028+28.0%€0.131€0.132€0.1261,010,112
€0.100-0.016-13.8%€0.131€0.132€0.0993,225,242
€0.116-0.004-3.3%€0.118€0.118€0.115286,060
€0.120+0.004+3.4%€0.103€0.120€0.1030
€0.116-0.001-0.9%€0.117€0.118€0.116499,378
€0.117+0.007+6.4%€0.098€0.119€0.098675,876
€0.110+0.004+3.8%€0.100€0.112€0.1000
€0.106+0.001+1.0%€0.093€0.107€0.0930
€0.1050.0000.0%€0.097€0.105€0.0960
€0.105+0.001+1.0%€0.098€0.105€0.0970
€0.104+0.004+4.0%€0.095€0.105€0.0940
€0.100-0.004-3.8%€0.092€0.101€0.0920
€0.104-0.009-8.0%€0.100€0.111€0.0990
€0.1130.0000.0%€0.101€0.113€0.1000
€0.113-0.002-1.7%€0.101€0.115€0.1010
€0.115-0.006-5.0%€0.119€0.119€0.114300,198
€0.121-0.002-1.6%€0.120€0.121€0.120253,960
€0.123+0.012+10.8%€0.114€0.132€0.1140
€0.111+0.007+6.7%€0.101€0.112€0.1010
€0.104+0.002+2.0%€0.093€0.106€0.0930
€0.1020.0000.0%€0.094€0.102€0.09437,600
€0.102+0.001+1.0%€0.091€0.102€0.0900
€0.1010.0000.0%€0.094€0.103€0.0940
€0.1010.0000.0%€0.095€0.103€0.0950
€0.1010.0000.0%€0.096€0.103€0.0960
€0.1010.0000.0%€0.094€0.105€0.094198,910
€0.101-0.029-22.3%€0.093€0.102€0.0920
€0.130+0.022+20.4%€0.108€0.131€0.107500
€0.108+0.001+0.9%€0.108€0.108€0.1050
€0.107-0.008-7.0%€0.114€0.115€0.107100,000
€0.115+0.016+16.2%€0.101€0.115€0.10110,000
€0.099-0.012-10.8%€0.099€0.101€0.0990
€0.111+0.010+9.9%€0.102€0.117€0.1000
€0.101+0.002+2.0%€0.097€0.102€0.0960
€0.099-0.001-1.0%€0.108€0.108€0.0980
€0.100-0.005-4.8%€0.106€0.107€0.1001,171,140
€0.105-0.006-5.4%€0.109€0.111€0.1040
€0.111-0.008-6.7%€0.117€0.117€0.1110
€0.119+0.001+0.8%€0.118€0.121€0.1180
€0.118-0.006-4.8%€0.123€0.124€0.1180
€0.124+0.015+13.8%€0.111€0.132€0.110200
€0.109-0.009-7.6%€0.119€0.119€0.1090
€0.118-0.006-4.8%€0.124€0.125€0.1170
€0.124-0.006-4.6%€0.134€0.134€0.1230
€0.130-0.013-9.1%€0.145€0.145€0.1297,300
€0.143+0.002+1.4%€0.140€0.143€0.13110
€0.141-0.037-20.8%€0.161€0.161€0.1390
€0.178+0.033+22.8%€0.115€0.178€0.115379,126
€0.145-0.015-9.4%€0.145€0.160€0.1430
€0.160+0.074+86.0%€0.160€0.160€0.0800
€0.086-0.004-4.4%€0.086€0.086€0.084887,200
€0.090-0.009-9.1%€0.099€0.099€0.0890
€0.099+0.024+32.0%€0.075€0.100€0.0740
€0.075+0.004+5.6%€0.074€0.075€0.0730
€0.071+0.010+16.4%€0.062€0.072€0.0620

Splits

1 split · FWB:0N6A · every price before a split is adjusted for it

DayRatioWhat
1-for-100Consolidation
Ticker
Frankfurt:0N6A
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All TME Pharma N.V. news

Financings

  • Bonds

    Nov 17, 2025 · US$1.94M

    Terms changed: €1.71M · Warrants at €0.1 for 24 months

    Buyers: D.M. van den Ouden (29% of the new bond issue); Mr. van den Ouden (will be issued 4,980,000 warrants to subscribe for up to 4,980,000 common shares); Diede van den Ouden (CEO; with 2 Supervisory Board members holds 29% of the May and August 2025 bonds); Maurizio PetitBon (50,000.00 € debt cash purchase amount); Lee Schalop (20,000.00 € debt cash purchase amount)

    Insiders: Holders who agreed in principle to a one-year extension are CEO Diede van den Ouden and 2 Supervisory Board members, holding 29% of the May and August 2025 bonds (face value €718,946)

    Use of proceeds: Support ongoing operations while seeking partners to advance the NOX-A12 and NOX-E36 clinical programs

    Announced May 21, 2025 · Update May 26, 2025 · Update May 27, 2025 · Terms changed Nov 17, 2025

  • Bonds

    Nov 17, 2025 · US$584,413

    Closed: €500,000 raised · Warrants at €0.11 for 21 months

    Buyers: Diede van den Ouden (CEO; with 2 Supervisory Board members holds 29% of the May and August 2025 bonds); Maurizio PetitBon (50,044.00 € subscription price; 639,272 warrants)

    Insiders: Holders who agreed in principle to a one-year extension are CEO Diede van den Ouden and 2 Supervisory Board members, holding 29% of the May and August 2025 bonds (face value €718,946)

    Use of proceeds: R&D, treasury investment strategy and search for acquisitions and partnerships in profitable businesses

    Announced Aug 25, 2025 · Closed Sep 1, 2025 · Terms changed Nov 17, 2025

  • Warrant exercise of new ordinary shares from exercise of Warrants Z

    Jun 27, 2025

    Closed: €249,396 raised · €0.2 a share

    Closed Jun 27, 2025

Read by 6ix AI from the company's releases

Decks

TME Pharma N.V. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
15 in the last 12 months · 34 in all · newest Nov 10, 2026 · oldest 2025
Decks
14 decks · latest June 2025

Where TME Pharma N.V. is listed

ListingExchangeCountryCurrency
Euronext:ALTME · Home listingEuronextFranceEUR
gettex:0N6AgettexGermanyEUR
LS Exchange:A3DMC3LS ExchangeGermanyEUR
Lang & Schwarz:A3DMC3Lang & SchwarzGermanyEUR
Turquoise:ALTMEPTurquoiseUnited KingdomEUR
Dusseldorf:0N6ADusseldorfGermanyEUR
Frankfurt:0N6A · This pageFrankfurtGermanyEUR
Hamburg:0N6AHamburgGermanyEUR
Munich:0N6AMunichGermanyEUR
Stuttgart:0N6AStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about TME Pharma N.V.